Скачать презентацию Human Genome Project Chapter 9 Central Points Скачать презентацию Human Genome Project Chapter 9 Central Points

d48d62cd7bd908f9a19cb00c4ec524a9.ppt

  • Количество слайдов: 33

Human Genome Project Chapter 9 Human Genome Project Chapter 9

Central Points (1) § Large, international project analyzing human genome § Gene mapping to Central Points (1) § Large, international project analyzing human genome § Gene mapping to locate human genes § Number of surprises as human genome analyzed

Central Points (2) § Scientists apply information from Human Genome Project (HGP) to medical Central Points (2) § Scientists apply information from Human Genome Project (HGP) to medical diagnosis and treatment § Gene therapy is a future application of the HGP § Ethical and legal aspects of the HGP discussed

Case A: The Future Tells All § Natalie had fetal cells collected from her Case A: The Future Tells All § Natalie had fetal cells collected from her blood § DNA of fetus analyzed § Fetal sequencing helped them “know” their baby before meeting it

9. 1 Goals of HGP (1) 1. Create maps of the human and other 9. 1 Goals of HGP (1) 1. Create maps of the human and other creatures’ genomes 2. Find location of all genes 3. Compile lists of expressed genes and nonexpressed sequences 4. Discover function of all genes

9. 1 Goals of HGP (2) 5. ID proteins encoded by genes and their 9. 1 Goals of HGP (2) 5. ID proteins encoded by genes and their functions 6. Compare genes and proteins between species 7. Analyze DNA differences between genomes 8. Set up and manage databases based on genomes discovered

HGP Timeline Cracking the Code of life Video Human genome Project Getting the letters HGP Timeline Cracking the Code of life Video Human genome Project Getting the letters out

LQT 1 Long QT syndrome Chromosome Maps §Map shows where all the genes are LQT 1 Long QT syndrome Chromosome Maps §Map shows where all the genes are located on each chromosome Diabetes type 2 Sickle cell anemia Multiple tumors of glands Chromosome 11 Fig. 9 -2, p. 156

Methods § Began in 1990, human genome ~3. 2 billion nucleotides § Required development Methods § Began in 1990, human genome ~3. 2 billion nucleotides § Required development of automated methods § Bioinformatics created software, web-based databases, and research tools to collect, analyze, and store information § Genomics: study of genomes

HGP Now § Portion that carries genes was sequenced in 2003 § Function of HGP Now § Portion that carries genes was sequenced in 2003 § Function of remaining 15% unknown and currently being sequenced § Sequenced portion studied to ID genes and assign functions § Proteomics: study of protein structure and function

9. 2 Gene Mapping § Genes close together on same chromosome tend to be 9. 2 Gene Mapping § Genes close together on same chromosome tend to be inherited together and show linkage § In 1936, hemophilia and color blindness found to be linked, both on X chromosome § Difficult to map genes on autosomes, requires very large families with two specific genetic traits

X-Linked Genes Location of hemophilia A gene Location of color blindness gene X Chromosome X-Linked Genes Location of hemophilia A gene Location of color blindness gene X Chromosome p. 147

Linked Genes Separate by Crossing Over § Separation of the two alleles is result Linked Genes Separate by Crossing Over § Separation of the two alleles is result of crossing over between two genes § Occurs randomly in meiosis § Frequency of crossing over related to distance between two genes § Linkage map of a chromosome can be constructed

Autosomal Linkage § ABO blood group and nail-patella syndrome Autosomal Linkage § ABO blood group and nail-patella syndrome

Crossing Over Crossing Over

Linkage or Genetic Map § Order of genes on a chromosome and distance between Linkage or Genetic Map § Order of genes on a chromosome and distance between them § Expressed as percentage of crossing-over events § 10% = 10 map units or centimorgans (c. M) apart § From this pedigree, frequency of crossing over: 2/16 = 12. 5%. or 12. 5 c. M (actual value ~10 c. M)

Human Linkage Map a b 10. 1 c. M c 6. 2 c. M Human Linkage Map a b 10. 1 c. M c 6. 2 c. M Fig. 9 -3, p. 147

Positional Cloning § Markers identified that show differences in: • Restriction enzyme cutting sites Positional Cloning § Markers identified that show differences in: • Restriction enzyme cutting sites • Number of repeated DNA sequences (i. e. , STRs) § Markers assigned to chromosomes § Used to follow genetic disorder in pedigrees § Map one gene at a time, and by late 1980 s, more than 3, 500 genes and markers

Genes Mapped by Positional Cloning Genes Mapped by Positional Cloning

DNA Sequencing Today § Can rapidly sequence DNA with computer programs § Sequence entire DNA Sequencing Today § Can rapidly sequence DNA with computer programs § Sequence entire DNA sequence in genome § Uses high-speed sequencers and computers § Allowed HGP to succeed

9. 3 Whole Genome Sequencing § Construct a genomic library that contains all sequences 9. 3 Whole Genome Sequencing § Construct a genomic library that contains all sequences in a genome § Fragments of DNA placed in a DNA sequencer § Generates nucleotide sequence (As, Cs, Gs, and Ts) § Assemblers (specialized software) produce sequence of genome

Finding Genes from Sequence § Software programs scan sequences, searching for promoter sequence § Finding Genes from Sequence § Software programs scan sequences, searching for promoter sequence § Sequences that follow promoter are genes § AA sequence determined by matching the nucleotide triplets to corresponding AA § ID protein encoded by this gene

9. 4 What Have We Learned? § > 3 billion nucleotides of DNA § 9. 4 What Have We Learned? § > 3 billion nucleotides of DNA § ~5% genes code for proteins § Many remnants of genome’s evolutionary history § > Half the genome is repetitive DNA

Types Repetitive DNA § 45%: transposons • New copies can move (or transpose) • Types Repetitive DNA § 45%: transposons • New copies can move (or transpose) • Most not functional • Do not replicate and move around § 17%: LINE 1 sequence § 10%: Alu sequences § Others including short tandem repeats (STRs)

Other Surprises from HGP § 20, 000– 25, 000 genes but > 500, 000 Other Surprises from HGP § 20, 000– 25, 000 genes but > 500, 000 known proteins (possibly exceed 2 million) § Possible mechanisms • During processing m. RNA, the coding segments can be rearranged • Proteins modified after synthesis § Human Proteome Project (HUPO): ID proteins, functions, and interactions

9. 5 How Can Information Be Used? 1. ID location of gene 2. Function 9. 5 How Can Information Be Used? 1. ID location of gene 2. Function of the protein encoded by this gene 3. How the mutated gene or its protein product results in a disorder § Allow development of treatments and medications

Cystic Fibrosis (CF) Gene § Positional cloning ID gene, long arm of chromosome 7 Cystic Fibrosis (CF) Gene § Positional cloning ID gene, long arm of chromosome 7 § Isolated nucleotide sequence, ID AA sequence of CF protein § Compared to databases of other organisms, protein in plasma membrane § Now developing medications

9. 6 Future of Genome Sequencing § New technologies to reduce cost and time 9. 6 Future of Genome Sequencing § New technologies to reduce cost and time § Make sequencing routine in medical care § Possible for doctors to monitor your health § Provide: • Information to reduce risks for certain diseases • Early diagnosis of conditions

9. 7 Gene Therapy § Recombinant DNA technology to treat genetic disorders § Transfer 9. 7 Gene Therapy § Recombinant DNA technology to treat genetic disorders § Transfer copies of normal genes into cells (or people) with defective copies of these genes § Normal genes directs synthesis of the normal protein

How Are Genes Transferred? § Cells removed from the body § Normal copies inserted How Are Genes Transferred? § Cells removed from the body § Normal copies inserted using virus, or vector § Cells grown in the laboratory § Checked that normal gene actively making protein § Cells transferred back into the body

First Gene Therapy Patient (1990) § Ashanti De. Silva had severe combined immunodeficiency disorder First Gene Therapy Patient (1990) § Ashanti De. Silva had severe combined immunodeficiency disorder (SCID) § No functional immune system, die from infection § Inserted gene for adenosine deaminase (ADA) into her white blood cells § Treated cells injected into her, allowed her to develop an immune system Ongoing dilemma: Parkinsons My father, my brother and me video

Problems with Gene Therapy § In many cases, gene therapy has not worked § Problems with Gene Therapy § In many cases, gene therapy has not worked § Few patients developed leukemia § At least two people died § Scientists working to correct problems § Need to develop new approaches to use genes to treatment genetic diseases § Gene patent video start 27: 33 - end 36: 33

9. 8 Legal and Ethical Issues 9. 8 Legal and Ethical Issues